Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Allergan gets FDA nod for first oral CGRP drug for migraine

Allergan gets FDA nod for first oral CGRP drug for migraine

eptinezumab from Alder Biopharma – now  owned by Lundbeck – in late-stage development.

The mission matters

The mission matters economics. As Deborah Dunsire, CEO of Lundbeck, put it, our industry demands a very high concentration of intellectual capital across a very wide range of disciplines.

Low-dose LSD looks safe for Alzheimer’s patients, but will it work?

Low-dose LSD looks safe for Alzheimer’s patients, but will it work? Other treatments targeting serotonin pathways in Alzheimer’s haven’t proved to be successful – such as Lundbeck and Otsuka’s 5-HT.

Darwinian leadership in the life sciences industry

Darwinian leadership in the life sciences industry Or, to use the crisper, to-the-point description given by Lundbeck’s Deborah Dunsire, to be a world-class life sciences company requires a very high concentration of intellectual capital

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder Lundbeck clearly agrees, saying the drug provides “immediate and complete bioavailability with high specificity and strong binding for suppression of…CGRP”. ... Deborah Dunsire, CEO, Lundbeck. Dunsire said Alder is “an excellent strategic fit for

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics